Creo Medical Share Price | |
---|---|
Price | 36.25 |
Bid | 36.00 |
Ask | 36.50 |
Change | 0.00 (0.00%) |
Volume | 299,147 |
Open | 36.25 |
High | 36.25 |
Low | 36.25 |
Prev. Close | 36.25 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 361.48m |
Market Capitalisation | £131.04m |
Market Size | 5,000 |
52 Week High | 49.00 |
52 Week High Date | 02-Jan-2024 |
52 Week Low | 23.25 |
52 Week Low Date | 08-Jun-2023 |
# Trades | 33 |
---|---|
Vol. Sold | 102,793 |
Sold Value | £37.23k |
Vol. Bought | 196,354 |
Bought Value | £71.47k |
PE Ratio | -2.504076 |
Earnings | -14.4764 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 16:21:29 | 36.495 | 3,491 | Buy* | 36.00 | 36.50 | 1,274 | O Ordinary |
26-Apr-24 | 16:04:45 | 36.40 | 35,000 | Buy* | 36.00 | 36.50 | 12.74k | O Ordinary |
26-Apr-24 | 16:00:58 | 36.18 | 5,627 | Sell* | 36.00 | 36.50 | 2,036 | O Ordinary |
26-Apr-24 | 15:57:39 | 36.50 | 1,369 | Buy* | 36.00 | 36.50 | 499.69 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 15:57:39 | 36.50 | 50 | Buy* | 36.00 | 36.50 | 18.25 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 15:44:02 | 36.40 | 7,142 | Buy* | 36.00 | 36.50 | 2,600 | O Ordinary |
26-Apr-24 | 15:37:42 | 36.40 | 13,700 | Buy* | 36.00 | 36.50 | 4,987 | O Ordinary |
26-Apr-24 | 15:34:02 | 36.40 | 3,000 | Buy* | 36.00 | 36.50 | 1,092 | O Ordinary |
26-Apr-24 | 15:15:04 | 36.16 | 10,289 | Sell* | 36.00 | 36.50 | 3,721 | O Ordinary |
26-Apr-24 | 15:13:30 | 36.40 | 1,359 | Buy* | 36.00 | 36.50 | 494.68 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
13-Mar-23 | 09-Mar-23 | Buy | Ivonne Cantu held the position of Independent Non-Executive Director at the time of this trade.Ivonne Cantu | 20.00 | GBX | 125,000 | 125,000 |
13-Mar-23 | 09-Mar-23 | Buy | John Bradshaw held the position of Independent Non-Executive Director at the time of this trade.John Bradshaw | 20.00 | GBX | 1,265,135 | 1,371,082 |
13-Mar-23 | 09-Mar-23 | Buy | David Gerard Woods held the position of Executive Director at the time of this trade.David Gerard Woods | 20.00 | GBX | 415,255 | 440,255 |
13-Mar-23 | 09-Mar-23 | Buy | Christopher Paul Hancock held the position of Chief Technology Officer at the time of this trade.Christopher Paul Hancock | 20.00 | GBX | 383,171 | 4,802,352 |
13-Mar-23 | 09-Mar-23 | Buy | Richard John Rees held the position of CFO at the time of this trade.Richard John Rees | 20.00 | GBX | 2,715,322 | 2,805,902 |